线:CAR-T/NK

Javier A Menendez1,2, Ruth Lupu3,4,5,6, Begoña Martin-Castillo2,7

  • 1Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Girona, Spain.

Frontiers in immunology
|November 24, 2025
PubMed
概括

治疗诱导的衰老 (TIS) 癌细胞对亡的预先准备较少,但BH3分析可以预测对CAR-T/NK细胞等免疫溶解疗法的反应.